Lista de obras -

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

scientific article published on 30 July 2020

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

artículo científico publicado en 2020

A serological assay to detect SARS-CoV-2 seroconversion in humans

artículo científico publicado en 2020

A serological assay to detect SARS-CoV-2 seroconversion in humans

artículo científico publicado en 2020

An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening

artículo científico publicado en 2020

Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus

artículo científico publicado en 2019

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

artículo científico publicado en 2019

CD4+ follicular regulatory T cells optimize the influenza virus-specific B cell response

artículo científico publicado en 2021

Characterization of novel cross-reactive influenza B virus hemagglutinin head specific antibodies that lack hemagglutinin inhibition activity

scientific article published on 09 September 2020

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

scientific article published on 06 July 2020

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

artículo científico publicado en 2020

Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice

scientific article published on 15 September 2020

Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 Hemagglutinin

scientific article published on 21 October 2019

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model

artículo científico publicado en 2019

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.

artículo científico publicado en 2018

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies

artículo científico publicado en 2020

Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice

artículo científico publicado en 2020

Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective

scientific article published on 22 September 2020

Human germinal centres engage memory and naive B cells after influenza vaccination

scientific article published on 31 August 2020

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults

scientific article published on 21 January 2020

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model

artículo científico publicado en 2020

Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs

article

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses

artículo científico publicado en 2020

Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

scientific article published on 03 November 2020

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

scientific article published on 28 October 2020

SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

artículo científico publicado en 2020

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine

artículo científico publicado en 2020

The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain

scientific article published on 12 August 2019

Lista de obras de

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

A serological assay to detect SARS-CoV-2 seroconversion in humans

A serological assay to detect SARS-CoV-2 seroconversion in humans

An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening

Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

CD4+ follicular regulatory T cells optimize the influenza virus-specific B cell response

Characterization of novel cross-reactive influenza B virus hemagglutinin head specific antibodies that lack hemagglutinin inhibition activity

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice

Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 Hemagglutinin

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies

Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice

Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective

Human germinal centres engage memory and naive B cells after influenza vaccination

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model

Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses

Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine

The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain